Dr. Belden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1015 Chestnut St
Suite 1020
Philadelphia, PA 19107Phone+1 215-955-7785Fax+1 215-955-9362
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Infectious Disease, 2001 - 2003
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1997 - 2000
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
Certifications & Licensure
- PA State Medical License 1998 - 2024
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011
Publications & Presentations
PubMed
- 1 citationsThe Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19.Marija Vukoja, Aysun Tekin, Nereida A Parada, JaVaughn C Gray, Alan Mallouhi
The Journal of Allergy and Clinical Immunology. in Practice. 2024-09-01 - Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.Tobias Siegfried Kramer, Alex Soriano, Sarah Tedeschi, Antonia F Chen, Pierre Tattevin
Open Forum Infectious Diseases. 2024-03-01 - 4 citationsShould We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.Tobias Siegfried Kramer, Alex Soriano, Sarah Tedeschi, Antonia F Chen, Pierre Tattevin
Open Forum Infectious Diseases. 2023-10-01
Press Mentions
- IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
- Monoclonal Antibody Drugs Raise Hopes for Keeping High-Risk COVID-19 Patients Out of the Hospital. But It’s ComplicatedNovember 24th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: